Departments: Practice Points
One effective tool for supporting outcomes is a clinical pathway. In my last column, “Clinical Pathways Integrated with Evidence-Based Decisions: Part 1,” we reviewed the diabetic pathway week 1. This column, and select references, focuses on the diabetic pathways weeks 4 and 20. Next month, we will review the Venous Etiology Clinical Pathways Integrated with Evidence-Based Decisions. We hope you find these references useful in creating process in your practice!
1. Snyder R, Kirsner R, Warriner R, Lavery L, Hanft J, Sheehan P. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manage 2010; 56 (suppl 4): S1–24.
2. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003; 26: 1879–82.
3. Kantor J, Margolis DJ. Expected healing rates for chronic wounds. Wounds 2000; 12 (6): 155–8.
4. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006; 14: 680–92.
5. Frykberg RG, Zgonis T, Armstrong DG, et al. American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg 2006; 45 (5 Suppl): S1–66.